6 March 2025
At the meeting of 4 February 2025 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| malignant neoplasm of the urethra | 19/2025 | 20/2025 |
| opisthorchiasis | 21/2025 | 22/2025 |
| otosclerosis | 23/2025 | 24/2025 |
| clonorchiasis | 25/2025 | 26/2025 |
| ischaemic heart disease | 27/2025 | 28/2025 |
| tooth loss | 29/2025 | 30/2025 |
| malignant neoplasm of the endometrium | 31/2025 | 32/2025 |
| pterygium | 33/2025 | 34/2025 |
| visual refractive error | 35/2025 | 36/2025 |
Note:
- The investigation concerning “loss of teeth” has resulted in the determination of Statements of Principles concerning tooth loss.
- The investigation concerning “myopia, hypermetropia and astigmatism” has resulted in the determination of Statements of Principles concerning visual refractive error.
The above SOPs take effect from 25 March 2025.
Completed Investigations
The above determinations conclude the previously advertised investigations into:
The above investigation notice appears in the Government Notices Gazette of 20 February 2025.